Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

"Evaluation of point of care viral load assays in resource limited settings, and synthesis of evidence to inform global policy on human immunodeficiency virus (HIV) monitoring and detection"

FY 2013-14

Summary
An estimated 34 million people are infected with human immunodeficiency virus (HIV) worldwide, with a significant majority residing in Sub-Saharan Africa. Although HIV-related deaths have decreased in the developed world as a result of the introduction of effective treatment, this only recently became available in African countries. Successful treatment for HIV now depends on timely diagnosis of HIV, and effective monitoring of disease progression to optimize treatment options. The stage of early (or acute) HIV infection has a high risk of transmission and is a critical period for diagnosis, to prevent spread of the virus and to initiate early treatment intervention. Following HIV diagnosis and treatment initiation, patients must be closely monitored for disease progression by testing the number of copies of the virus in the blood, also known as the viral load. Timely viral load testing is crucial for determining treatment effectiveness, drug resistance, treatment adherence, as well as initiating switches to second-line treatment when needed. While various tests and strategies are presently available in resource-rich settings for diagnosing early HIV infections and determining viral load, there is an urgent need for cost-effective tests that are feasible in resource-limited settings. The proposed study will synthesize evidence on the performance and accuracy of all viral load and acute HIV tests currently on the market, through a systematic review of all relevant scientific literature to date. This review will produce evidence on the accuracy of tests and performance against a reference standard, in addition to all patient-centred outcomes, economic outcomes, and impact on clinical decision-making. In addition, in a cross sectional study of new patients who show up for treatment initiation, we will conduct a head-to-head performance comparison of two brand-new, state-of-the-art viral load tests and one rapid HIV diagnostic test in a high-prevalence, low-resource setting. The study will be conducted at a clinic in South Africa, and about 350 participants will undergo testing with the three new tests, plus a third to be used as a reference for true viral load. The performance of each test and agreement between them will be determined, as well as their ability to accurately detect viral load. Operational characteristics of each test will also be analysed to determine the feasibility of implementing the test in a resource-limited setting. This evidence is yet unavailable and is much needed to make global policy for detecting acute HIV and viral load monitoring. This research will have significant implications for controlling the global HIV epidemic, preventing the spread of the virus through early diagnosis and initiation of quick and effective treatment. The WHO, MSF and the Gates Foundation have all recognized the necessity of viral load testing, and it is clear that a critical evaluation of the performance of these tests is long overdue. Examining the overall performance of these tests across global settings will produce crucial evidence for making informed decisions on quality treatment monitoring and diagnostic testing systems.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
312022
Name
Smallwood Megan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
"Evaluation of point of care viral load assays in resource limited settings, and synthesis of evidence to inform global policy on human immunodeficiency virus (HIV) monitoring and detection"
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Infection; Diagnostics; Hiv; Hiv Testing; Immunoassays; Point Of Care Tests; Rapid Tests; Resource Limited Settings; Treatment Monitoring; Viral Load
Abstract
An estimated 34 million people are infected with human immunodeficiency virus (HIV) worldwide, with a significant majority residing in Sub-Saharan Africa. Although HIV-related deaths have decreased in the developed world as a result of the introduction of effective treatment, this only recently became available in African countries. Successful treatment for HIV now depends on timely diagnosis of HIV, and effective monitoring of disease progression to optimize treatment options. The stage of early (or acute) HIV infection has a high risk of transmission and is a critical period for diagnosis, to prevent spread of the virus and to initiate early treatment intervention. Following HIV diagnosis and treatment initiation, patients must be closely monitored for disease progression by testing the number of copies of the virus in the blood, also known as the viral load. Timely viral load testing is crucial for determining treatment effectiveness, drug resistance, treatment adherence, as well as initiating switches to second-line treatment when needed. While various tests and strategies are presently available in resource-rich settings for diagnosing early HIV infections and determining viral load, there is an urgent need for cost-effective tests that are feasible in resource-limited settings. The proposed study will synthesize evidence on the performance and accuracy of all viral load and acute HIV tests currently on the market, through a systematic review of all relevant scientific literature to date. This review will produce evidence on the accuracy of tests and performance against a reference standard, in addition to all patient-centred outcomes, economic outcomes, and impact on clinical decision-making. In addition, in a cross sectional study of new patients who show up for treatment initiation, we will conduct a head-to-head performance comparison of two brand-new, state-of-the-art viral load tests and one rapid HIV diagnostic test in a high-prevalence, low-resource setting. The study will be conducted at a clinic in South Africa, and about 350 participants will undergo testing with the three new tests, plus a third to be used as a reference for true viral load. The performance of each test and agreement between them will be determined, as well as their ability to accurately detect viral load. Operational characteristics of each test will also be analysed to determine the feasibility of implementing the test in a resource-limited setting. This evidence is yet unavailable and is much needed to make global policy for detecting acute HIV and viral load monitoring. This research will have significant implications for controlling the global HIV epidemic, preventing the spread of the virus through early diagnosis and initiation of quick and effective treatment. The WHO, MSF and the Gates Foundation have all recognized the necessity of viral load testing, and it is clear that a critical evaluation of the performance of these tests is long overdue. Examining the overall performance of these tests across global settings will produce crucial evidence for making informed decisions on quality treatment monitoring and diagnostic testing systems.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Smallwood, Megan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~